Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Lucchini E, Zaja F, Bussel J.

Haematologica. 2019 Jun;104(6):1124-1135. doi: 10.3324/haematol.2019.218883. Epub 2019 May 24. Review.

2.
3.

Management of immune thrombocytopenia in elderly patients.

Lucchini E, Fanin R, Cooper N, Zaja F.

Eur J Intern Med. 2018 Dec;58:70-76. doi: 10.1016/j.ejim.2018.09.005. Epub 2018 Sep 29. Review.

PMID:
30274902
4.

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study.

Rossi G, Gramegna D, Paoloni F, Fattizzo B, Binda F, D'Adda M, Farina M, Lucchini E, Mauro FR, Salvi F, Marchetti M, Fazi P, Zaja F, Barcellini W.

Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13. No abstract available.

PMID:
29898955
5.

Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.

Righi E, Carnelutti A, Muser D, Zaja F, Lucchini E, Pea F, Di Gregorio F, Alavi A, Bassetti M.

J Neurovirol. 2017 Dec;23(6):908-912. doi: 10.1007/s13365-017-0566-4. Epub 2017 Aug 18.

PMID:
28822107
6.

Voice Improvement in Patients with Functional Dysphonia Treated with the Proprioceptive-Elastic (PROEL) Method.

Lucchini E, Ricci Maccarini A, Bissoni E, Borragan M, Agudo M, González MJ, Romizi V, Schindler A, Behlau M, Murry T, Borragan A.

J Voice. 2018 Mar;32(2):209-215. doi: 10.1016/j.jvoice.2017.05.018. Epub 2017 Jul 18.

PMID:
28732751
7.

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

Marangon M, Vianelli N, Palandri F, Mazzucconi MG, Santoro C, Barcellini W, Fattizzo B, Volpetti S, Lucchini E, Polverelli N, Carpenedo M, Isola M, Fanin R, Zaja F.

Eur J Haematol. 2017 Apr;98(4):371-377. doi: 10.1111/ejh.12839. Epub 2017 Jan 20.

PMID:
27981682
8.

Targeting the epidermal growth factor receptor in solid tumors: focus on safety.

Lucchini E, Pilotto S, Spada E, Melisi D, Bria E, Tortora G.

Expert Opin Drug Saf. 2014 May;13(5):535-49. doi: 10.1517/14740338.2014.904283. Epub 2014 Apr 1. Review.

PMID:
24684184
9.

[Comparison of SAPS II, MPM II24 and SAPS in intensive care].

Cominotti S, Chiaranda M, Mascetti P, Lucchini E, Severgnini P.

Minerva Anestesiol. 1999 Oct;65(10):717-23. Italian.

PMID:
10598429
10.

Yohimbine and aldosterone responsiveness to angiotensin II or corticotrophin in normal subjects.

Lucchini E, Kressebuch H, Beretta-Piccoli C.

Clin Exp Hypertens A. 1989;11(4):649-63.

PMID:
2551545
11.

[Methods for preventing complications of central venous catheterization].

Lucchini E, Minoja G, Goddi A, Bortoluzzi E.

Minerva Anestesiol. 1986 Jan-Feb;52(1-2):35-41. Italian. No abstract available.

PMID:
3526182
12.

Out-of-hospital cardiac arrest: 6 month follow-up.

Minoja G, Bandera A, Sala R, Lucchini E, De Pietri P.

Lancet. 1985 Oct 5;2(8458):775. No abstract available.

PMID:
2864502
13.

New England Deaconess Hospital podiatry service. Sport orthotic device.

Donovan JC, Scardina RJ, Frykberg RG, Hill CE Jr, Lucchini E.

J Am Podiatry Assoc. 1979 Sep;69(9):571-4. No abstract available.

PMID:
489875

Supplemental Content

Loading ...
Support Center